EMBC Embecta Corp.
Embecta Corp. (EMBC) is expected to report earnings on November 6, 2026, before the market open. The consensus earnings estimate is $0.31 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +23.2% since its last earnings release on August 7, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Embecta Corp.
embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe.
Sector
Healthcare
Industry
Medical Instruments/Supply